
Language
Search
Product News
- Software Newsletter #37 - New TopSpin patch level 3 for version 2.1 now available
- Bruker Announces Order for 10 NMR Systems to Enable World-Class Scientific Research at King...
- Faster diagnoses thanks to new scanning technology
- Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
- Bruker BioSpin's MRI CryoProbe(TM) Selected for 2008 R&D 100 Award for Enabling Preclinical MRI on...
Bruker Announces Order for 10 NMR Systems to Enable World-Class Scientific Research at King Abdullah University of Science and Technology (KAUST)
Saudi Order Includes the World's Highest Field NMR Systems for Structural Biology (950 MHz) and for Solid State (850 MHz Widebore) Research
BILLERICA, Mass., Nov 19, 2008 (BUSINESS WIRE) -- Bruker BioSpin announces today that it has received an order from King Abdullah University of Science and Technology (KAUST) for ten (10) Nuclear Magnetic Resonance (NMR) spectrometers valued at close to $20 million, including Bruker's flagship 950 MHz superconducting NMR magnet. KAUST is a new graduate-level research university in Saudi Arabia, dedicated to inspiring a new age of scientific achievement and the realization of a vision of King Abdullah.
The two-story, eight-ton 950 MHz magnet is the world's highest-field superconducting actively shielded high-resolution NMR magnet system. The heart of this 950 MHz NMR magnet is a proprietary coil set made of about 100 miles of superconducting wire which is producing a 22.3 Tesla magnetic field. The large magnet will allow scientists to investigate the structure of bio-molecules and study their interactions with greater resolution and sensitivity than ever before.
The 950 MHz magnet at the center of KAUST's NMR facility will be surrounded by other Bruker NMR spectrometers, ranging from 400 MHz for chemistry up to an actively-shielded 850 MHz widebore magnet for solid-state NMR. All Bruker NMR systems ordered will include the Bruker next-generation AVANCE™ III NMR console, which incorporates second-generation (2G) digital receiver (DR) technology for a significant further improvement in NMR detection fidelity. This 2G-DR technology and Bruker's leading NMR probe and CryoProbe™ technology provide a new level of performance for demanding NMR experiments in structural biology, chemistry and material sciences.
The broad range of NMR systems ordered will enable KAUST to offer leading-edge capabilities for NMR research to its scientists and academic partners. Installation of these NMR systems is expected to begin in 2009 and to continue into 2010, with many of them targeted to be operational for the planned opening of KAUST in September 2009.
"We look forward at KAUST to exploit the advanced capabilities of the NMR systems manufactured by Bruker," stated Dr. Mohamed E. Samaha, interim VP for Research at KAUST. "These systems will be utilized to expand the boundaries of the scientific knowledge. They are an integral constituent to realize King Abdullah's vision and our overall plans to build one of the world's leading scientific research institutions for the prosperity and development of Saudi Arabia and the world."
CAUTIONARY STATEMENT
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the integration of businesses we have acquired or may acquire in the future, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, intellectual property rights, litigation, and exposure to foreign currency fluctuations. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2007, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements other than as required by law.
SOURCE: Bruker Corporation
Bruker BioSpin Corporation
Brenda Prost, +1 978-667-9580 ext. 5188
brenda.prost@bruker-biospin.com
